An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Update Il y a 4 ans
Reference: NCT00744757

Woman and Man

Extract

The purpose of this study is to evaluate the response rate of decitabine in previously treated and untreated Taiwanese participants with Myelodysplastic Syndrome (MDS - a disease associated with decreased production of blood cells, blood cells are produced but do not mature normally).


Inclusion criteria

  • myelodysplastic syndrome

Links